Aisling Capital Management LP 13F Portfolio
| Entity | Category | QoQ AUM Change | AUM (13F) | # of Holdings | Performance Rank | Equities Trend |
|---|---|---|---|---|---|---|
AC Aisling Capital Management LP | Institutional Filer | ▼ 0.55% | $476.3M | 13 |
Current Portfolio Holdings
Showing all 13 reported positions by value
| # | Stock | Company Name | Sector | Shares Held | Market Value | % of Portfolio |
|---|---|---|---|---|---|---|
| 1 | BBIO | BridgeBio Pharma, Inc. | Healthcare | 5.1M | $378.0M | 79.35% |
| 2 | SNDX | Syndax Pharmaceuticals, Inc. | Healthcare | 1.3M | $30.8M | 6.46% |
| 3 | GLUE | Monte Rosa Therapeutics, Inc. | Healthcare | 1.6M | $25.6M | 5.37% |
| 4 | BCAX | Bicara Therapeutics Inc. Common Stock | Healthcare | 569K | $11.3M | 2.38% |
| 5 | BBOT | BridgeBio Oncology Therapeutics Inc. | Healthcare | 1.0M | $9.1M | 1.91% |
| 6 | CMPS | COMPASS Pathways plc | Healthcare | 1.4M | $7.9M | 1.66% |
| 7 | SRRK | Scholar Rock Holding Corporation | Healthcare | 77K | $3.8M | 0.80% |
| 8 | BMEA | Biomea Fusion, Inc. | Healthcare | 2.0M | $3.1M | 0.66% |
| 9 | EPRX | Eupraxia Pharmaceuticals Inc. | Healthcare | 325K | $2.4M | 0.49% |
| 10 | URGN | UroGen Pharma Ltd. | Healthcare | 108K | $1.9M | 0.41% |
| 11 | ACRS | Aclaris Therapeutics, Inc. | Healthcare | 434K | $1.6M | 0.34% |
| 12 | MRKR | Marker Therapeutics, Inc. | Healthcare | 325K | $423K | 0.09% |
| 13 | OKUR | OnKure Therapeutics, Inc. | Healthcare | 89K | $367K | 0.08% |
Showing 1 to 13 of 13 holdings